Literature DB >> 32584130

Influence of Cilostazol on Changes in Cyclin D1 Expression in Cerebral Cortex of Rats with Chronic Cerebral Ischemia.

A-X Wei1, M-Y Shao, Y Liu, Y Sun, L-M Wang, X-Y Ma, J Mang, Z-X Xu.   

Abstract

The influence of cilostazol on learning and memory, and cyclin D1 expression in the cerebral cortex of rats with chronic cerebral ischemia were investigated. A chronic cerebral ischemia model was established using the permanent bilateral common carotid artery occlusion method (2VO), learning and memory capacity was detected using the Morris water maze, and expression changes in apoptosis regulating gene cyclin D1 were tested by RT-PCR. Results of the Morris water maze indicated that significant extensions were found in the escape latent period and swimming path of rats in the ischemia group (2VO group), learning and memory results in the cilostazol group was obviously superior compared to the 2VO group (P<0.05), and the expression of cyclin D1 was observed to increase in both the ischemia and cilostazol intervention groups at the 9th week of ischemia. A significant difference was observed, compared with the sham operation group (P<0.05), the expression level decreased in the ischemia group compared with the cilostazol group, and a significant difference was identified compared with the ischemia group (P<0.05). Cilostazol can reduce nerve function impairment and improve learning and memory functions by affecting changes in apoptosis regulating genes.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32584130      PMCID: PMC8549885          DOI: 10.33549/physiolres.934282

Source DB:  PubMed          Journal:  Physiol Res        ISSN: 0862-8408            Impact factor:   1.881


  8 in total

Review 1.  Activation of cell-cycle-associated proteins in neuronal death: a mandatory or dispensable path?

Authors:  A Copani; D Uberti; M A Sortino; V Bruno; F Nicoletti; M Memo
Journal:  Trends Neurosci       Date:  2001-01       Impact factor: 13.837

2.  Cilostazol attenuates gray and white matter damage in a rodent model of focal cerebral ischemia.

Authors:  Fumiaki Honda; Hideaki Imai; Makoto Ishikawa; Chisato Kubota; Tatsuya Shimizu; Mari Fukunaga; Nobuhito Saito
Journal:  Stroke       Date:  2005-12-08       Impact factor: 7.914

3.  Neuroprotective effect of cilostazol against focal cerebral ischemia via antiapoptotic action in rats.

Authors:  Jae Moon Choi; Hwa Kyoung Shin; Ki Young Kim; Jeong Hyun Lee; Ki Whan Hong
Journal:  J Pharmacol Exp Ther       Date:  2002-03       Impact factor: 4.030

4.  Cilostazol suppresses superoxide production and expression of adhesion molecules in human endothelial cells via mediation of cAMP-dependent protein kinase-mediated maxi-K channel activation.

Authors:  So Youn Park; Jeong Hyun Lee; Chi Dae Kim; Won Suk Lee; Won Sun Park; Jin Han; Yong-Geun Kwak; Ki Young Kim; Ki Whan Hong
Journal:  J Pharmacol Exp Ther       Date:  2006-03-17       Impact factor: 4.030

5.  Neuroprotection by cilostazol, a phosphodiesterase type 3 inhibitor, against apoptotic white matter changes in rat after chronic cerebral hypoperfusion.

Authors:  Jeong Hyun Lee; So Youn Park; Yung Woo Shin; Ki Whan Hong; Chi Dae Kim; Sang-Min Sung; Ki Young Kim; Won Suk Lee
Journal:  Brain Res       Date:  2006-03-03       Impact factor: 3.252

6.  An oral administration of cilostazol before focal ischemia reduces the infarct volume with delayed cerebral blood flow increase in rats.

Authors:  Izumi Yuzawa; Masaru Yamada; Kiyotaka Fujii
Journal:  J Stroke Cerebrovasc Dis       Date:  2008-09       Impact factor: 2.136

7.  Cilostazol improves cognitive function in mice by increasing the production of insulin-like growth factor-I in the hippocampus.

Authors:  Juan Zhao; Naoaki Harada; Hiroki Kurihara; Naomi Nakagata; Kenji Okajima
Journal:  Neuropharmacology       Date:  2009-12-24       Impact factor: 5.250

Review 8.  Vascular cognitive impairment.

Authors:  John T O'Brien
Journal:  Am J Geriatr Psychiatry       Date:  2006-09       Impact factor: 4.105

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.